Neurocognitive changes and negative symptoms in schizophrenia;Neurokognitive veränderungen und negativ-symptomatik bei schizophrenen erkrankungen

Fortschritte der Neurologie Psychiatrie

Volumn 73, Issue 6, 2005, Pages 333-342

  Thoma, Patrizia ^a   Daum, I ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM;

BASAL GANGLION; COGNITION; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISORIENTATION; FRONTAL CORTEX; GENETIC HETEROGENEITY; HUMAN; INHIBITION (PSYCHOLOGY); MENTAL DISEASE; MENTAL PERFORMANCE; NEUROBIOLOGY; PROBLEM SOLVING; REVIEW; SCHIZOPHRENIA;

COGNITION; HUMANS; PROBLEM SOLVING; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 21244496474     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-830233     Document Type: Review

References (107)

1. Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, Day R, Bertelsen A. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl 1992; 20: 1-97
2. Knapp M, Mangalore R, Simon J. The global costs of schizophrenia. Schizophr Bull 2004; 30: 279-293
3. Kraepelin E. Dementia Praecox and Paraphrenia. Zinkin J (trans) New York: International Universities Press Inc, 1950
4. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998; 12: 426-445
5. Snitz B, Daum I. The Neuropsychology of Schizophrenia: A Selective Review. Z Neuropsychologie 2001; 12 (1): 3-7
6. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996; 153: 321-330
7. Simon AE, Giacomini V, Ferrero F, Mohr S. Dysexecutive syndrome and social adjustment in schizophrenia. Aust N Z J Psychiatry 2003; 37: 340-346
8. Luria AR. Higher cognitive functions in man. New York: Basic Books, 1980
9. Lezak MD. Neuropsychological Assessment. New York: NY Oxford, 1995
10. Crow TJ. Positive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiatry 1980; 137: 383-386
11. Liddle PF. The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br J Psychiatry 1987; 151: 145-151
12. Andreasen NC. Symptoms, signs, and diagnosis of schizophrenia. Lancet 1995; 346: 477-481
13. Carpenter Jr WT, Arango C, Buchanan RW, Kirkpatrick B. Deficit psychopathology and a paradigm shift in schizophrenia research. Biol Psychiatry 1999; 46: 352-360
14. Donohoe G, Robertson IH. Can specific deficits in executive functioning explain the negative symptoms of schizophrenia? A review. Neurocase 2003; 9: 97-108
15. Tandon R, DeQuardo JR, Taylor SF, McGrath M, Jibson M, Eiser A, Goldman M. Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome. Schizophr Res 2000; 45: 191-201
16. Tamminga CA, Buchanan RW, Gold JM. The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. Int Clin Psychopharmacol 1998; 13 Suppl 3: 21-26
17. Hughlings-Jackson J. Selected Writings. Taylor J (Hrsg). London: Hodder and Stoughton Ltd, 1931
18. Brown RG, Pluck G. Negative symptoms: the "pathology" of motivation and goal-directed behaviour. Trends Neurosci 2000; 23: 412-417
19. Frith CD, Done DJ. Towards a neuropsychology of schizophrenia. Br J Psychiatry 1988; 153: 437-443
20. Carpenter Jr WT, Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 1988; 145: 578-583
21. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter Jr WT. The Schedule for the Deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res 1989; 30: 119-123
22. Arango C, Buchanan RW, Kirkpatrick B, Carpenter Jr WT. The deficit syndrome in schizophrenia: implications for the treatment of negative symptoms. Eur Psychiatry 2004; 19: 21-26
23. Buchanan RW, Gold JM. Negative symptoms: diagnosis, treatment and prognosis. Int Clin Psychopharmacol 1996; 11 Suppl 2: 3-11
24. Addington J, Addington D. Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia. J Psychiatry Neurosci 1993; 18: 18-23
25. Agerbo E, Byrne M, Eaton WW, Mortensen PB. Marital and labor market status in the long run in schizophrenia. Arch Gen Psychiatry 2004; 61: 28-33
26. Arango C, Adami H, Sherr JD, Thaker GK, Carpenter Jr WT. Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness. Am J Psychiatry 1999; 156: 1097-1099
27. Kirkpatrick B, Buchanan RW, Breier A, Carpenter Jr WT. Depressive symptoms and the deficit syndrome of schizophrenia. J Nerv Ment Dis 1994; 182: 452-455
28. Fenton WS, McGlashan TH, Victor BJ, Blyler CR. Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders. Am J Psychiatry 1997; 154: 199-204
29. Kirkpatrick B, Amador XF, Flaum M, Yale SA, Gorman JM, Carpenter Jr WT, Tohen M, McGlashan T. The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse. Schizophr Res 1996; 20: 69-77
30. Lewine RR. Sex differences in schizophrenia: timing or subtypes? Psychol Bull 1981; 90: 432-434
31. Ring N, Tantam D, Montague L, Newby D, Black D, Morris J. Gender differences in the incidence of definite schizophrenia and atypical psychosis - focus on negative symptoms of schizophrenia. Acta Psychiatr Scand 1991; 84: 489-496
32. Scully PJ, Coakley G, Kinsella A, Waddington JL. Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia. Psychol Med 1997; 27: 1303-1310
33. Arango C, Kirkpatrick B, Buchanan RW. Neurological signs and the heterogeneity of schizophrenia. Am J Psychiatry 2000; 157: 560-565
34. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol Bull 1988; 24: 97-99
35. Berman KF, Weinberger DR. Prefrontal dopamine and defect symptoms in schizophrenia. In: Greden JF, Tandon R (Hrsg). Negative schizophrenic symptoms: Psychophysiology and clinical implications. Washington DC: American Psychiatric Press, 1991: 81-95
36. Davis KL, Kahn RS, Ko G, Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 1991; 148: 1474-1486
37. Goff DC, Coyle JT. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 2001; 158: 1367-1377
38. Tandon R, Greden JF. Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/dopaminergic interactions in schizophrenia. Arch Gen Psychiatry 1989; 46: 745-753
39. Goff DC, Evins AE. Negative symptoms in schizophrenia: neurobiological models and treatment response. Harv Rev Psychiatry 1998; 6: 59-77
40. Lieberman JA, Sheitman BB, Kinon BJ. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 1997; 17: 205-229
41. Weinberger DR, Wyatt RJ. Brain morphology in schizophrenia: In vivo studies. In: Henn FA, Nasrallah HA (Hrsg). Schizophrenia as a Brain Disease. New York: Oxford University Press, 1982
42. Andreasen NC, Flaum M, Swayze VW, Tyrrell G, Arndt S. Positive and negative symptoms in schizophrenia. A critical reappraisal. Arch Gen Psychiatry 1990; 47: 615-621
43. d'Amato T, Rochet T, Dalery J, Laurent A, Chauchat JH, Terra JL, Marie-Cardine M. Relationship between symptoms rated with the Positive and Negative Syndrome Scale and brain measures in schizophrenia. Psychiatry Res 1992; 44: 55-62
44. Johnstone EC, Crow TJ, Frith CD, Husband J, Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976; 2: 924-926
45. Borgerts B. Bedeutung des Frontalhirns für die Pathophysiologie schizophrener Erkrankungen. In: Förstl H (Hrsg). Frontalhirn: Funktionen und Erkrankungen. Berlin, Heidelberg: Springer, 2002: 181-205
46. Sanfilipo M, Lafargue T, Rusinek H, Arena L, Loneragan C, Lautin A, Rotrosen J, Wolkin A. Cognitive performance in schizophrenia: relationship to regional brain volumes and psychiatric symptoms. Psychiatry Res 2002; 116: 1-23
47. Coger RW, Serafetinides EA. Schizophrenia, corpus callosum, and interhemispheric communication: a review. Psychiatry Res 1990; 34: 163-184
48. Kandel ER. Disorders of Thought and Volition: Schizophrenia. In: Kandel ER, Schwartz JH, Jessell TM (Hrsg). Principles of Neural Science. 4th International Edition. New York: McGraw Hill, 2000: 1188-1207
49. Goethals I, Audenaert K, Van de Wiele C, Dierckx R. The prefrontal cortex: insights from functional neuroimaging using cognitive activation tasks. Eur J Nucl Med Mol Imaging 2004; 31: 408-416
50. Royall DR, Lauterbach EC, Cummings JL, Reeve A, Rummans TA, Kaufer DI, LaFrance Jr WC, Coffey CE. Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 2002; 14: 377-405
51. Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 1990; 85: 119-146
52. Velligan DI, Bow-Thomas CC. Executive function in schizophrenia. Semin Clin Neuropsychiatry 1999; 4: 24-33
53. Hutton SB, Puri BK, Duncan LJ, Robbins TW, Barnes TR, Joyce EM. Executive function in first-episode schizophrenia. Psychol Med 1998; 28: 463-473
54. Trestman RL, Keefe RS, Mitropoulou V, Harvey PD, deVegvar ML, Lees-Roitman S, Davidson M, Aronson A, Silverman J, Siever LJ. Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder. Psychiatry Res 1995; 59: 127-136
55. Goldberg TE, Torrey EF, Gold JM, Bigelow LB, Ragland RD, Taylor E, Weinberger DR. Genetic risk of neuropsychological impairment in schizophrenia: a study of monozygotic twins discordant and concordant for the disorder. Schizophr Res 1995; 17: 77-84
56. Gambini O, Campana A, Garghentini G, Scarone S. No evidence of a homogeneous frontal neuropsychological profile in a sample of schizophrenic subjects. J Neuropsychiatry Clin Neurosci 2003; 15: 53-57
57. Evans JJ, Chua SE, McKenna PJ, Wilson BA. Assessment of the dysexecutive syndrome in schizophrenia. Psychol Med 1997; 27: 635-646
58. Buchanan RW, Strauss ME, Kirkpatrick B, Holstein C, Breier A, Carpenter Jr WT. Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. Arch Gen Psychiatry 1994; 51: 804-811
59. Wagman AM, Heinrichs DW, Carpenter Jr WT. Deficit and nondeficit forms of schizophrenia: neuropsychological evaluation. Psychiatry Res 1987; 22: 319-330
60. Baxter RD, Liddle PF. Neuropsychological deficits associated with schizophrenic syndromes. Schizophr Res 1998; 30: 239-249
61. Brazo P, Marie RM, Halbecq I, Benali K, Segard L, Delamillieure P, Langlois-Thery S, Van der Elst A, Thibaut F, Petit M, Dollfus S. Cognitive patterns in subtypes of schizophrenia. Eur Psychiatry 2002; 17: 155-162
62. Woodward TS, Ruff CC, Thornton AE, Moritz S, Liddle PF. Methodological considerations regarding the association of Stroop and verbal fluency performance with the symptoms of schizophrenia. Schizophr Res 2003; 61: 207-214
63. Hepp HH, Maier S, Hermle L, Spitzer M. The Stroop effect in schizophrenic patients. Schizophr Res 1996; 22 (3): 187-195
64. Perlstein WM, Carter CS, Barch DM, Baird JW. The Stroop task and attention deficits in schizophrenia: a critical evaluation of card and single-trial Stroop methodologies. Neuropsychology 1998; 12: 414-425
65. Waters FA, Badcock JC, Maybery MT, Michie PT. Inhibition in schizophrenia: Association with auditory hallucinations. Schizophr Res 2003; 62(3): 275-280
66. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-276
67. Burgess PW, Shallice T. Response suppression, initiation and strategy use following frontal lobe lesions. Neuropsychologia 1995; 34 (4): 263-272
68. Gale HJ, Holzman PS. A new look at reaction time in schizophrenia. Schizophr Res 2000; 46: 149-165
69. Reuter B, Kathmann N. Using saccade tasks as a tool to analyze executive dysfunctions in schizophrenia. Acta Psychol (Amst) 2004; 115: 255-269
70. Muller N, Riedel M, Eggert T, Straube A. Internally and externally guided voluntary saccades in unmedicated and medicated schizophrenic patients. Part II. Saccadic latency, gain, and fixation suppression errors. Eur Arch Psychiatry Clin Neurosci 1999; 249: 7-14
71. Tien AY, Ross DE, Pearlson G, Strauss ME. Eye movements and psychopathology in schizophrenia and bipolar disorder. J Nerv Ment Dis 1996; 184: 331-338
72. McDowell JE, Brown GG, Paulus M, Martinez A, Stewart SE, Dubowitz DJ, Braff DL. Neural correlates of refixation saccades and antisaccades in normal and schizophrenia subjects. Biol Psychiatry 2002; 51: 216-223
73. Heyder K, Suchan B, Daum I. Cortico-subcortical contributions to executive control. Acta Psychol (Amst) 2004; 115: 271-289
74. Burgess PW, Veitch E, de Lacy CA, Shallice T. The cognitive and neuroanatomical correlates of multitasking. Neuropsychologia 2000; 38: 848-863
75. Granholm E, Asarnow RF, Marder SR. Controlled information processing resources and the development of automatic detection responses in schizophrenia. J Abnorm Psychol 1991; 100: 22-30
76. Schwartz F, Munich RL, Carr A, Bartuch E, Lesser B, Rescigno D, Viegener B. Negative symptoms and reaction time in schizophrenia. J Psychiatr Res 1991; 25: 131-140
77. Fuller R, Jahanshahi M. Concurrent performance of motor tasks and processing capacity in patients with schizophrenia. J Neurol Neurosurg Psychiatry 1999; 66: 668-671
78. Cameron AM, Oram J, Geffen GM, Kavanagh DJ, McGrath JJ, Geffen LB. Working memory correlates of three symptom clusters in schizophrenia. Psychiatry Res 2002; 110: 49-61
79. Reitan RM. Trail Making-Test (Adult Version). USA: Reitan Neuropsychology Laboratory, 1992
80. Mahurin RK, Velligan DI, Miller AL. Executive-frontal lobe cognitive dysfunction in schizophrenia: a symptom subtype analysis. Psychiatry Res 1998; 79: 139-149
81. Allen DN, Anastasiou A, Goldstein G, Gilbertson M, van Kammen DP. Influence of haloperidol on the relationship of frontal lobe function to psychomotor poverty and disorganization syndromes. Psychiatry Res 2000; 93: 33-39
82. O'Leary DS, Flaum M, Kesler ML, Flashman LA, Arndt S, Andreasen NC. Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia. J Neuropsychiatry Clin Neurosci 2000; 12: 4-15
83. Pantelis C, Harvey CA, Plant G, Fossey E, Maruff P, Stuart GW, Brewer WJ, Nelson HE, Robbins TW, Barnes TR. Relationship of behavioural and symptomatic syndromes in schizophrenia to spatial working memory and attentional set-shifting ability. Psychol Med 2004; 34: 693-703
84. Nieuwenstein MR, Aleman A, de Haan EH. Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting-Test. Continuous Performance-Test. J Psychiatr Res 2001; 35: 119-125
85. Milner B. Effects of brain lesions on card sorting. Arch Neurol 1963; 9: 90-100
86. Liu Z, Tam WC, Xie Y, Zhao J. The relationship between regional cerebral blood flow and the Wisconsin Card Sorting-Test in negative schizophrenia. Psychiatry Clin Neurosci 2002; 56: 3-7
87. Braver TS, Barch DM, Cohen JD. Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function. Biol Psychiatry 1999; 46: 312-328
88. Thoma P, Zoppelt D, Wiebel B, Daum I. Context processing and negative symptoms in schizophrenia. (Manuskript eingereicht)
89. Cohen JD, Barch DM, Carter C, Servan-Schreiber D. Context-processing deficits in schizophrenia: converging evidence from three theoretically motivated cognitive tasks. J Abnorm Psychol 1999; 108: 120-133
90. Kerns JG, Berenbaum H. The relationship between formal thought disorder and executive functioning component processes. J Abnorm Psychol 2003; 112: 339-352
91. Docherty NM, DeRosa M, Andreasen NC. Communication disturbances in schizophrenia and mania. Arch Gen Psychiatry 1996; 53: 358-364
92. Menon V, Anagnoson RT, Mathalon DH, Glover GH, Pfefferbaum A. Functional neuroanatomy of auditory working memory in schizophrenia: relation to positive and negative symptoms. Neuroimage 2001; 13: 433-446
93. Perlstein WM, Carter CS, Noll DC, Cohen JD. Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. Am J Psychiatry 2001; 158: 1105-1113
94. Shallice T. Specific impairments of planning. Philos Trans R Soc Lond B Biol Sci 1982; 298 (1089): 199-209
95. Andreasen NC, Rezai K, Alliger R, Swayze VW, Flaum M, Kirchner P, Cohen G, O'Leary DS. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 1992; 49: 943-958
96. Andreasen NC. Scale for the Assessment of Negative Symptoms (SANS). Iowa City: The University of Iowa, 1983
97. Ludewig K, Paulus MP, Vollenweider FX. Behavioural dysregulation of decision-making in deficit but not nondeficit schizophrenia patients. Psychiatry Res 2003; 119: 293-306
98. Paulus MP, Hozack NE, Zauscher BE, Frank L, Brown GG, McDowell J, Braff DL. Parietal dysfunction is associated with increased outcome-related decision-making in schizophrenia patients. Biol Psychiatry 2002; 51: 995-1004
99. Andres P. Frontal cortex as the central executive of working memory: time to revise our view. Cortex 2003; 39: 871-895
100. Ready RE, Stierman L, Paulsen JS. Ecological validity of neuropsychological and personality measures of executive functions. Clin Neuropsychol 2001; 15 (3): 314-323
101. Semkovska M, Stip E, Godbout L, Paquet F, Bedard MA. Behavioral dis-organization in schizophrenia during a daily activity: the kitchen behavioral scoring scale. Brain Cogn 2002; 48: 546-553
102. Liddle PF. Syndromes in schizophrenia and their neuropsychological and neuroanatomical correlates. In: Pantelis C, Nelson HE, Barnes TRE (Hrsg). Schizophrenia: A neuropsychological Perspective. Chichester: John Wiley, 1996
103. Schatz J. Cognitive processing efficiency in schizophrenia: generalized vs domain specific deficits. Schizophr Res 1998; 30: 41-49
104. Andreasen NC. Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: The University of Iowa, 1984
105. Kasper S, Resinger E. Cognitive effects and antipsychotic treatment. Psychoneuroendocrinology 2003; 28 Suppl 1: 27-38
106. Medalia A, Revheim N, Casey M. Remediation of problem-solving skills in schizophrenia: evidence of a persistent effect. Schizophr Res 2002; 57: 165-171
107. Bellucci DM, Glaberman K, Haslam N. Computer-assisted cognitive rehabilitation reduces negative symptoms in the severely mentally ill. Schizophr Res 2003; 59: 225-232